IDHC.L
現在値
1.03USD変化
-0.00(-0.02%)出来高
131,932本日のレンジ
-
1.0352週レンジ
-
1.45∙ 約20分前の相場を表示しています。
前日終値 | 1.03 |
|---|---|
始値 | 1.03 |
出来高 | 131,932 |
3か月平均出来高 | 6.91 |
高値 | 1.03 |
安値 | 1.02 |
52週高値 | 1.45 |
52週安値 | 1.02 |
発行済株式数 | 600.00 |
時価総額 | 1,247.33 |
予想PER | 11.29 |
配当利回り | 9.25 |
Integrated Diagnostics Holdings To Buy Evercare Group's 50% Stake In Islamabad Diagnostic Centre
Integrated Diagnostics Holdings 9 Months Revenue Increases By 126% Year-On-Year
IDH Partners With IFC On $45 Mln Debt Financing
Integrated Diagnostics Holdings plc (IDH) is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. It is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). It operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).
業種
Healthcare Facilities
エグゼクティブリーダーシップ
Anthony T. St John
Non-Executive Independent Chairman
Hend El Sherbini
Group Chief Executive Officer, Executive Director
Omar Bedewy
Chief Financial Officer
Richard Henry Phillips
Non-Executive Director
Yvonne Stillhart
Non-Executive Director
株価売上高倍率（過去12カ月） | -- |
|---|---|
株価売上高倍率（過去12カ月） | -- |
株価純資産倍率（四半期） | 4.37 |
株価キャッシュフロー倍率 | -- |
総負債／総資本（四半期） | 33.25 |
長期負債／資本（四半期） | 27.94 |
投資利益率(過去12カ月） | -- |
自己資本利益率（過去12カ月) | -- |
金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。